itraconazole has been researched along with Critical Illness in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 2 (22.22) | 2.80 |
Authors | Studies |
---|---|
Lu, F; Wang, B; Wang, Y; Xu, Y; Zhang, L; Zhang, M | 1 |
Alencar, RRFR; Antonio, BVR; Franco, EDS; Leal, PC; Oliveira, RD; Santos, LMD | 1 |
Irlbeck, M; Jung, J; Kallee, S; Kneidinger, N; Liebchen, U; Michel, S; Paal, M; Scharf, C; Schneider, C; Schroeder, I; Vogeser, M; Zander, J; Zoller, M | 1 |
Antoniadou, E; Belesiotou, E; Dimopoulos, G; Giamarellos-Bourboulis, EJ; Katsenos, C; Mandragos, K; Maraki, S; Pistiki, A; Routsi, C; Samonis, G; Solomonidi, N; Stamou, A; Tasioudis, C; Vlachogianni, G | 1 |
Qui, HB | 1 |
Borges Sá, M; Garnacho Montero, J | 1 |
Havlícek, K; Mencl, K; Motycka, V; Ninger, V; Safusová, L; Sákra, L | 1 |
Chakrabarti, A; Reddy, TC; Singhi, SC | 1 |
Kintzel, PE; List, AF; Rollins, CJ; Yee, WJ | 1 |
1 review(s) available for itraconazole and Critical Illness
Article | Year |
---|---|
[Role of anidulafungin in critically ill patients].
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Critical Illness; Cross Infection; Drug Therapy, Combination; Echinocandins; Fluconazole; Fungemia; Humans; Immunocompetence; Intensive Care Units; Itraconazole; Practice Guidelines as Topic | 2008 |
1 trial(s) available for itraconazole and Critical Illness
Article | Year |
---|---|
[Clinical efficacy and safety of itraconazole injection/oral solution sequential therapy for treatment of invasive fungal infection in intensive care unit].
Topics: Adult; Aged; Antifungal Agents; Critical Illness; Female; Humans; Intensive Care Units; Itraconazole; Male; Middle Aged; Mycoses; Treatment Outcome | 2008 |
7 other study(ies) available for itraconazole and Critical Illness
Article | Year |
---|---|
Surveillance Study of Epidemiology, Antifungal Susceptibility and Risk Factors of Invasive Candidiasis in Critically ill Patients.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Candidiasis, Invasive; Critical Illness; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Risk Factors; Voriconazole | 2022 |
Discrete cutaneous lesions in a critically ill patient treated only for AIDS and miliary tuberculosis: a case report of disseminated histoplasmosis.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Anti-HIV Agents; Antifungal Agents; Antitubercular Agents; Critical Illness; Dermatomycoses; Histoplasma; Histoplasmosis; Humans; Itraconazole; Male; Tuberculosis, Miliary; Young Adult | 2019 |
Comparing posaconazole and itraconazole for antifungal prophylaxis in critically ill lung transplant recipients: Efficacy and plasma concentrations.
Topics: Antifungal Agents; Critical Illness; Humans; Itraconazole; Lung; Retrospective Studies; Transplant Recipients; Triazoles | 2021 |
Susceptibility profiles and clinical efficacy of antifungals against candida bloodstream isolates from critically ill patients: Focus on intravenous itraconazole.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candidemia; Critical Illness; Female; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Treatment Outcome | 2019 |
[Preemptive antimycotic therapy in critically ill patients].
Topics: Antifungal Agents; Candidiasis; Critical Illness; Female; Humans; Itraconazole; Male; Premedication; Retrospective Studies; Risk Factors | 2003 |
Oral itraconazole in treatment of candidemia in a pediatric intensive care unit.
Topics: Administration, Oral; Antifungal Agents; Candida; Candidiasis; Case-Control Studies; Chi-Square Distribution; Child; Child, Preschool; Critical Illness; Cross Infection; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Fungemia; Humans; India; Infant; Intensive Care Units, Pediatric; Itraconazole; Male; Probability; Retrospective Studies; Statistics, Nonparametric; Treatment Outcome | 2004 |
Low itraconazole serum concentrations following administration of itraconazole suspension to critically ill allogeneic bone marrow transplant recipients.
Topics: Adult; Bone Marrow Transplantation; Burkitt Lymphoma; Chemistry, Pharmaceutical; Critical Illness; Humans; Intubation, Gastrointestinal; Itraconazole; Lymphoma, Non-Hodgkin; Male; Suspensions | 1995 |